Ascendis Pharma · 2 days ago
Senior Clinical Scientist - Job ID: 1845
Palo Alto, CA
Full-time
Hybrid
Mid, Senior Level
$170K/yr - $190K/yr
4+ years expAscendis Pharma is a dynamic, fast-growing global biopharmaceutical company advancing programs in Endocrinology Rare Disease and Oncology. The Senior Clinical Scientist is responsible for the design, monitoring, and data analysis of late-phase clinical trials studying various therapies, contributing to the Clinical Development team.
BiotechnologyClinical TrialsHealth Care
Responsibilities
For clinical trials: design, provide oversight, and support site and subject retention
Ensure successful completion of documents (including clinical trial protocols, investigator brochures, monitoring plans, site training materials, clinical study reports, health authority responses, standard operating procedures, etc.) with cross-functional team members
Participate on study teams and cross-functional teams as appropriate, and as delegated by the Vice President, Clinical Development
Ensure consistent use of language and criteria across multiple endocrine projects
Ensure study integrity, and track accumulating safety and efficacy data
Anticipate obstacles within a clinical trial, and implement solutions
Analyze, evaluate, and support accurate interpretation and reporting of clinical data
Contribute to drafting and reviewing clinical documents, manuscripts, presentations, and regulatory submissions
Maintain up-to-date knowledge of relevant science, medical information, good clinical practices, and regulatory guidance
Collaborate with—and serve as a clinical research resource for—cross-functional colleagues to optimize product development
Cultivate relationships with investigative sites, clinical consultants, and key opinion leaders to represent the interests of the company
Support corporate strategic and organizational initiatives
Assist with commercial activities as needed
Complete assigned tasks thoroughly, accurately, and on time
Adhere to rigorous ethical standards
Travel up to 20% domestically and internationally for scientific meetings
Qualification
Required
Advanced degree e.g. Ph.D., Pharm.D., MS, or equivalent
Strong track record of scientific and clinical inquiry
Understand statistical concepts and clinical trial design
Understand the connection between nonclinical data and clinical data
Possess excellent communication skills (both written and verbal)
Learn quickly, follow complex directions under pressure
Multi-task while remaining organized and attentive to detail
Work hard, be a trustworthy and collaborative team player
Take initiative and solve problems of moderate complexity
Demonstrate sound judgement in terms of handling complex, confidential, and regulated information
Lead both directly and by example
Preferred
At least 4 years of experience with clinical trial design and execution
At least 4 years of pharmaceutical industry experience
Experience with regulatory submissions and interactions
Benefits
401(k) plan with company match
Medical, dental, and vision plans
Company-offered Life and Accidental Death & Dismemberment (AD&D) insurance
Company-provided short and long-term disability benefits
Unique offerings of Pet Insurance and Legal Insurance
Employee Assistance Program
Employee Discounts
Professional Development
Health Saving Account (HSA)
Flexible Spending Accounts
Various incentive compensation plans
Accident, Critical Illness, and Hospital Indemnity Insurance
Mental Health resources
Paid leave benefits for new parents
Company
Ascendis Pharma
Ascendis Pharma built a high-value pipeline that aims to change the clinical treatment paradigms.
1001-5000 employees
H1B Sponsorship
Ascendis Pharma has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (1)
2023 (6)
2022 (4)
2021 (3)
2020 (1)
Funding
Current Stage
Public CompanyTotal Funding
$1.88BKey Investors
Royalty Pharma
2024-09-19Post Ipo Equity· $300M
2024-09-03Post Ipo Debt· $150M
2023-09-05Post Ipo Debt· $150M
Leadership Team
Ivanna Rosendal
Senior Director, IT Business Partner
Keren Tenenbaum
US General Counsel and Chief Compliance Officer
Recent News
2026-01-11
2026-01-11
Company data provided by crunchbase